Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 51
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Completed
18 and over
Pharmaceutical / Industry
CZOL446GUS45
ZENITH, NCT00063609
2.
A Multiple Myeloma Trial in Patients With Bone Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Completed
18 and over
Pharmaceutical / Industry
CZOL446EUS97
US97, NCT00104104
3.
Zoledronic Acid in the Prevention of Skeletal-Related Events in Hormone Refractory and Hormone-Sensitive Prostate Cancer Patients With Bone Metastases
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Completed
18 to 120
Pharmaceutical / Industry
CZOL446EIT04
NCT00219219
4.
Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Closed
18 to 80
Pharmaceutical / Industry
CZOL446GGR01
NCT00219271
5.
Evaluation of the Efficacy and Tolerability of Zoledronic Acid in Combination With Radiotherapy in Patients With Advanced Osteolytic Bone Lesions
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Closed
18 and over
Pharmaceutical / Industry
CZOL446EDE06
NCT00171964
6.
Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Biomarker/Laboratory analysis, Treatment
Closed
18 to 75
Other
CZOL446ECN05
NCT00524849
Last Modified:
11/1/2001
 
First Published:
5/1/1999
7.
Phase III Randomized Study of Zoledronate Versus Pamidronate in Patients With Cancer-Related Bone Lesions Due to Multiple Myeloma or Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
Pharmaceutical / Industry
NOVARTIS-4244603010
UCLA-9911015
Last Modified:
5/31/2007
 
First Published:
7/1/1999
8.
Phase III Randomized Study of Zoledronate With or Without Antineoplastic Therapy in Patients with Any Solid Tumor with Bone Metastases Other than Breast Cancer or Prostate Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Closed
18 and over
Pharmaceutical / Industry
NOVARTIS-4244603011
NCT00003884
Last Modified:
10/20/2007
 
First Published:
7/1/1999
9.
Phase III Randomized Study of Zoledronate in Patients With Bone Metastases Secondary to Prostate Cancer (Summary Last Modified 12/1999)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
NOVARTIS-4244603039
Last Modified:
11/12/2007
 
First Published:
4/1/2000
10.
Phase III Randomized Study of Zoledronate and Standard Therapy vs Placebo and Standard Therapy in Patients With Asymptomatic Recurrent Prostate Cancer Who Have Castrate Levels of Testosterone and Rising PSA Levels
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
NCI
UCLA-9908030
NOVARTIS-CZOL4460704, NCI-G00-1722, NCT00005073
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute